Get startedLog in
    Picture of Drug Free Solution logo

    DSOL — Drug Free Solution Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Drug Free Solution, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

    2011
    May 31st
    R2012
    May 31st
    2013
    May 31st
    Period Length:2 M12 M12 M
    Source:PROSPECTUS10-K10-K
    Standards:
    USG
    USG
    USG
    Status:FinalFinalFinal
    Total Revenue000
    Selling / General / Administrative Expenses
    Total Operating Expenses00.5480.756
    Operating Profit-0-0.548-0.756
    Other Net Non Operating Costs
    Net Income Before Taxes-0-0.626-0.756
    Provision for Income Taxes
    Net Income After Taxes-0-0.626-0.756
    Net Income Before Extraordinary Items
    Net Income-0-0.626-0.756
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income-0-0.626-0.756
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0-0.012-0.011
    Dividends per Share